Bacterial strains, plasmids, and media. Mutant plasmids were maintained in E. coli KK535 (thr leu thi deo tonA lacY supE44 recA nalA nrdA nrdB [22] ). E. coli C600 (thr-J leu-6 thi-l supE44 lacYJ tonA21) was the host of pBR322 and pPS2 in some experiments. Plasmid pPS2 is a recombinant derivative of pBR322 (4) and codes for both subunits of E. coli ribonucleotide reductase (21). Plasmid clones pPS305, pPS308, pPS317, and pPS319 were obtained after in vitro mutagenesis of pPS2 DNA. Plasmid-carrying cells were grown in L-broth (18) containing 10 jig of tetracycline per ml.
Ribonucleotide reductase is an allosterically regulated enzyme which catalyzes the reduction of ribonucleoside diphosphates to their corresponding deoxyribonucleotides. A 1:1 complex of two nonidentical subunits, proteins B1 and B2, constitutes the active holoenzyme in Escherichia coli (27) . The Bi protein contains two substrate binding sites as well as redox-active sulfhydryl groups which participate in the enzymatic reaction (25) . In vitro studies have earlier shown that the allosteric behavior is mediated by the binding of nucleoside triphosphates to the Bi subunit (7, 28) . The effector binding sites are of two classes and have been denoted h and I (for high and low affinity for dATP). The binding specificity of the enzyme for a particular substrate is determined by binding of the effectors ATP, dATP, dTTP, or dGTP to the h sites (specificity sites). Binding to sites regulates the overall activity of the enzyme. Only ATP (positive effector) and dATP (negative effector) bind to these sites. It-has been proposed that the enzyme in the cell can exist in at least three active and one inactive forms and that the transitions between the different allosteric states are important for a balanced supply of all four deoxyribonucleotides needed for DNA synthesis (23) .
It should be possible to obtain a better understanding of the in vivo significance of the allosteric regulation observed in vitro by isolation and analyses of mutants which affect the Bi subunit. We recently described the construction of such mutants by in vitro mutagenesis of the recotnbinant plasmid pPS2 coding for both subunits of rnbonucleotide reductase (21, 22) . In the present paper we examine the regulation of the catalytic activity and the effector nucleotide binding behavior of four mutant Bi proteins by affinity chromatography (28) , catalytic measurements, and direct photoaffinity labeling (10) . The in vivo effects of these mutations on deoxynucleotide pools in cells carrying the corresponding recombinant plasmids were also investigated. Bacterial strains, plasmids, and media. Mutant plasmids were maintained in E. coli KK535 (thr leu thi deo tonA lacY supE44 recA nalA nrdA nrdB [22] ). E. coli C600 (thr-J leu-6 thi-l supE44 lacYJ tonA21) was the host of pBR322 and pPS2 in some experiments. Plasmid pPS2 is a recombinant derivative of pBR322 (4) and codes for both subunits of E. coli ribonucleotide reductase (21) . Plasmid (2).
MATERIALS AND METHODS

Materials
Photoaffinity labeling. The photochemical reaction was performed as described earlier (10, 24) (22) . Extracts from 14 of these clones were screened with affinity chromatography on dATP-and dGTP-Sepharose. Adsorption-desorption patterns which differed from that of normal Bi (B1lt) were obtained with extracts from clones pPS317 and pPS319 (Table 1) . Protein B1317 was more retarded than B1wt on the dGTP-Sepharose, and 29% of B1317 remained after the specific elution step.
Protein B1319 was more retarded than B1,t on both dATPand dGTP-Sepharose. In this case 21 and 34%, respectively, remained in the guanidine chloride eluate ( Table 1 ).
The desorption of Bl.t and B1319 from dATP-and dGTPSepharose media was further studied with linear gradients of the competing nucleotide (0 to 7 mM ATP or 0 to 50 p.M dGTP). Protein B1,t eluted from the dATP-Sepharose at an ATP concentration of 1 to 2 mM (Fig. 1A) . Protein B1319 showed a more retarded and broader distribution than Blwt and eluted at concentrations ranging from 2 to 7 mM ATP (Fig. 1B) . When adsorbed to dGTP-Sepharose, B1Nl, eluted as a sharp peak at 3 p.M dGTP (Fig. 1C) . For protein B1319 the elution profile from dGTP-Sepharose was significantly broader and was distributed at concentrations ranging from 3 to 15 p.M dGTP (Fig. 1D) .
The B1 proteins from clones pPS305 and pPS308, already earlier classified as B1 missense mutants (22) , behaved indistinguishably from Blwt on both dATP-and dGTPSepharose (Table 1) .
Catalytic and allosteric characterization of mutant Bi proteins. In the preliminary characterization in crude lysates, proteins B1317 and B1319 displayed about half the activity of Blwt (22) . As highly purified preparations, B1317 and B1319 showed essentially the same CDP reducing activity as homogeneous Blwt ( Table 2 ). The only difference in CDP reducing activity occurred at inhibitory concentrations of dATP (4 x 10-4 M), where the mutant proteins appeared more susceptible than the wild type. Three further deviations from wild-type behavior were obvious in B1317 as well as in B1319 (Table 2 ). Both mutant proteins showed approximately 30% more efficient reduction of UDP in the presence of dTTP and 50 to 60% more efficient reduction of UDP and GDP in the presence of dGTP. Because dGTP is regarded as a prime effector for reduction of purine ribonucleotides (27) , these differences were further characterized for GDP reduction in the presence of increasing amounts of dGTP. Apparent Km values were calculated from effector saturation curves and were expressed as the concentration of dGTP required to give half-maximal stimulation of GDP reduction (2) . The apparent Km for Blt was 2.0 p.M (Fig. 2) ; a value similar to that which was earlier observed for B1wt prepared from thymine-starved cells (6, 17, 29) . The apparent Km for B1319 was considerably lower, and half-maximal stimulation of GDP reduction occurred at 0.8 ,uM dGTP (Fig. 2) . For (Table 4) . Each plasmid maintained its characteristic pool sizes in wild-type cells (strain C600) as well as in the nrd-defective strain (KK535) ( Table 4 concentration close to the Kdi,, for this substrate. A preliminary characterization of the four mutant B1 proteins was performed with direct photoaffinity labeling.
The mutant Bi proteins showed a photoincorporation of dTTP similar to that of B1lw except for protein B1308, in which incorporation of dTTP was less affected by the presence of the substrate GDP than it was for Blwt, B1305, B1317, or B1319 ( Fig. 3A and B) . When the data were plotted in a double-reciprocal form, the total maximal incorporation per Bi dimer, as well as the concentration of dTTP required to give half-maximal incorporation, could be determined by extrapolation of the linear curves. In the absence of GDP, the half-maximal concentration needed was about two-to fourfold lower for B1305, B1317, and B1319 than for B1wt or B1308 (Table 3) . However, this difference was not reflected in the total incorporation of dTTP into the various Bi proteins ( Fig. 3A and B ; Table 3 ). An experiment in which dGTP was added during the photolabeling with dTTP was performed with Blwt, B1305, and B1308 (Fig. 3C ). As expected, the presence of dGTP prevented the photoincorporation of dTTP into all three B1 proteins due to competition for the same allosteric site. In agreement with the results in Fig. 3A and B and Table 3 , the same concentration of dGTP was required to give 50% inhibition of dTTP incorporation, indicating a very similar binding affinity for these ligands to the various Bi proteins. high dTTP pool in KK535 cells carrying pBR322 is probably caused by the deoBIC mutation of KK535, which renders these cells unable to catabolize deoxyribose 1-phosphate and thereby promotes the conversion of exogenous thymine to dTTP (20) . Levels of deoxyribonucleoside triphosphates in cells with mutant Bi proteins. For clones pPS305, pPS308, pPS317, and pPS319 the deoxyribonucleotide pools were measured in the KK535 background (Table 4) . In comparison to the parent plasmid, pPS2, clones pPS305 and pPS308 had drastically lowered pyrimidine pools which were even lower than in the pBR322 strain. The purine deoxynucleotide levels were equal or close to those of the pPS2 strain.
In the pPS317 strain the dGTP pool was decreased to the level of the pBR322 strain. Also the dTTP pool was decreased, but the dCTP and dATP pools were close to pPS2 values. In clone pPS319 the primary effects were on the dGTP and dTTP pools, which were diminished to the pBR322 levels. A slightly decreased dCTP pool was also found, but the dATP pool did not differ from the pPS2 level.
DISCUSSION
The purpose of this investigation was to examine the in vivo consequences of single missense mutations in the Bi protein of E. coli ribonucleotide reductase. Two clones, pPS305 and pPS308, had extremely low reducing capacity, and the other two clones, pPS317 and pPS319, had aberrant chromatographic behavior on affinity media. All four clones synthesized B1 polypeptide of normal length as judged from sodium dodecyl sulfate-polyacrylamide gel electrophoresis and were consequently classified as Bi missense mutants.
Catalytically defective phenotypes may be caused by a variety of unspecific mutations, but in B1305 and B1308 more subtle and specific lesions seem probable since both proteins behaved similarly to Blwt in the photoaffinity labeling experiment. Because B1305 also behaved like B1wt in the GDPmediated binding of dTTP, the mutation in pPS305 affects the active site of Bl and most likely its association with other components of the ribonucleotide reductase system. Protein B1308, apart from its low reducing activity, differs from Blwt have in vivo consequences in the form of impaired deoxyribonucleotide pools. Although these in vivo effects are specific for pyrimidine nucleotides, a similar type of selectivity could not be corroborated in vitro in either mutant clone. This discrepancy probably reflects the fact that the intracellular levels of the four substrates and the effector molecules differ from the conditions used for the kinetic studies performed in vitro.
Clones pPS317 and pPS319 also suffer from very specific lesions, since both Bi proteins have enzymatic activities similar to that of B1,t. On the other hand, both mutant proteins have pronounced alterations in their allosteric behavior. B1317 differs from B1wt in its binding to dGTPSepharose, its dTTP-mediated reduction of UDP, and its dGTP-mediated reduction of GDP and UDP. Protein B1319 differs from B1wt in its binding to both affinity media tested.
The defect is further manifested in a lower apparent Km for dGTP, higher dTTP-mediated reduction of UDP, higher dGTP-mediated reduction of GDP and UDP, and stronger inhibitory regulation by dATP. Protein B1319 thus has a phenotype that is partly similar to but more pleiotropic than that of B1317, but in both cases these effects suggest a stronger in vitro affinity for dGTP and possibly dTTP. The photoaffinity labeling results also indicate enhanced binding of dTTP to B1317 and B1319 in the absence of GDP (Table 3) . This could be interpreted as a more fixed conformation of B1317 and B1319, associated with a high affinity for dTTP. However, it is not apparent to us how these changed allosteric properties can cause the deoxyribonucleotide pool imbalances observed in vivo in pPS317 and pPS319, characterized by low dGTP and dTTP levels but virtually unaffected dCTP and dATP levels. (1) isolated a hydroxyurea-resistant 3T6 mouse fibroblast cell line. Extracts from these cells, like E. coli carrying pPS2, showed increased ribonucleotide reductase activity and primanly a three-to fourfold increase of the dATP pool. Generally increased deoxyribonucleotide triphosphate pools were also found in mutant 3T6 mouse fibroblasts containing an altered ribonucleotide reductase enzyme, which was resistant to dATP inhibition (19) . From such observations and the known allosteric regulation of ribonucleotide reductase in vitro, allosteric turn-off of the enzyme by dATP has been implicated as a mechanism for balancing the level of deoxyribonucleotides in the wild type as well as in mutants (9, 11, 19, 23 (22) . It is plausible that this restriction on ribonucleotide reduction also limits deoxyribonucleotide pool expansion in pPS2-containing cells.
